Portfolio Companies

BiOptix Diagnostics, Inc.

Diagnostic Instruments: Label-free Biodetectors and Bionanoslides

Shareholders in Portfolio Company 
RUSNANO, Boulder Ventures Ltd. (USA), Peierls Foundation (USA), private co-investors, BioNanoPhysics Research and Education Center of Moscow Institute of Physics and Technology

Industry Sector 
Medicine and Pharmacology

Production Location 
Dolgoprudny, Moscow Oblast

Investment Started:  2011

Total Budget

0.54  bln rubles
Co-investment by RUSNANO
0.13  bln rubles

Production of label-free biodetectors and, in Russia, production of disposable bionanoslides, both developed by American company BiOptix Diagnostics, Inc.

BiOptixBiOptix Diagnostics, Inc., in collaboration with 2005 Nobel Prize laureate in physics John Hall, has developed a unique technology for biodetection. The biodetectors developed by BiOptix provide extremely sensitive label-free biomolecule interaction analysis in real time. This kind of measurements is essential for development of promising molecular candidates for innovation drugs.

The BiOptix biodetector does not require florescent or isotope labeling of biomolecules. This saves time and reagents and, more importantly, facilitates study that was previously unachievable.

BiOptix biodetectorAreas of application

  • Molecular diagnostics

Market

  • Pharmaceutical companies
  • Scientific research institutes and universities

Competitive advantages

  • Low acquisition and use costs
  • Compactness
  • Simplicity of use
  • Reliability